Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -8 of 8
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
5/1/1998
1.
Phase III Study of Wide Excision versus Wide Excision plus Intraoperative Lymphatic Mapping with Isosulfan Blue (Lymphazurin) for Melanoma (Summary Last Modified 05/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Diagnostic, Treatment
Closed
18 to 75
Other
RPCI-DS-94-24
NCI-V97-1194
Last Modified:
1/1/1998
 
First Published:
11/1/1997
2.
Phase II Diagnostic Study of Intraoperative Lymph Node Mapping for Primary Breast Cancer Using Technetium Tc 99m Sulfur Colloid and Isosulfan Blue (Summary Last Modified 01/98)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Diagnostic
Closed
Over 18
NCI
RPCI-DS-95-14
NCI-G97-1333
First Published:
2/26/2008
3.
Phase II Study of Intraoperative Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Testing in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Diagnostic, Treatment
Closed
18 and over
NCI
JWCI-GULS-CRCSLN-0104
GULS-CRCSLN-0104, NCT00625625
Last Modified:
3/2/2005
 
First Published:
3/1/1998
4.
Diagnostic Study of Isosulfan Blue for Dynamic In Vivo Lymphography and Sentinel Node Biopsy in Patients With Colorectal Cancer (Summary Last Modified 04/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Completed
18-75
NCI
RPCI-DS-96-57
NCI-G98-1371, NCT00003186
Last Modified:
1/23/2008
 
First Published:
3/1/2001
5.
Pilot Study of Preoperative Lymphoscintigraphy Followed by Intraoperative Lymphatic Mapping for Sentinel Node Localization and Biopsy in Patients With Previously Untreated Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Completed
18 to 70
NCI
NYU-9917
NCI-G01-1915, NCT00012168
Last Modified:
7/29/2008
 
First Published:
9/24/2003
6.
Diagnostic Study of Lymphatic Mapping and Sentinel Node Identification in Patients With Stage IB1 Cervical Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic, Treatment
Closed
Not specified
NCI
GOG-0206
NCT00070317
Last Modified:
1/24/2008
 
First Published:
2/16/2007
7.
Study of Subareolar Injection as the Site For Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic
Closed
Not specified
NCI
MDA-ID-01538
NCT00438477
8.
Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Diagnostic, Treatment
Closed
Not specified
Other
02-127
NCT00595725
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute